Clinical Trial Update: CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential drug–drug interactions between Telmisartan/S-Amlodipine and Rosuvastatin completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• Telmisartan/S-amlodipine

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension, Hyperlipidemia | Phase 1 | Status: COMPLETED